BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37803433)

  • 21. Capn4 is induced by and required for Epstein-Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP-1 signaling.
    Zheng P; Chen X; Xie J; Chen X; Lin S; Ye L; Chen L; Lin J; Yu X; Zheng M
    Cancer Sci; 2020 Jan; 111(1):72-83. PubMed ID: 31691433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
    Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
    PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.
    Hau PM; Tsang CM; Yip YL; Huen MS; Tsao SW
    PLoS One; 2011; 6(6):e21176. PubMed ID: 21701587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
    Ng YK; Wong EY; Lau CP; Chan JP; Wong SC; Chan AS; Kwan MP; Tsao SW; Tsang CM; Lai PB; Chan AT; Lui VW
    Invest New Drugs; 2012 Feb; 30(1):48-58. PubMed ID: 20694504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
    Kondo S; Okabe A; Nakagawa T; Matsusaka K; Fukuyo M; Rahmutulla B; Dochi H; Mizokami H; Kitagawa Y; Kurokawa T; Mima M; Endo K; Sugimoto H; Wakisaka N; Misawa K; Yoshizaki T; Kaneda A
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166598. PubMed ID: 36372158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
    Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
    Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma.
    Xu J; Deng X; Tang M; Li L; Xiao L; Yang L; Zhong J; Bode AM; Dong Z; Tao Y; Cao Y
    PLoS One; 2013; 8(3):e56114. PubMed ID: 23472069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
    Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
    J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells.
    Du C; Wen B; Li D; Lin Y; Zheng Y; Peng X; Hong C; Chen J; Lin W; Hong X; Xie L; Wu M
    Tumori; 2006; 92(2):140-8. PubMed ID: 16724694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
    Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
    Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr Virus LMP1-Activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties.
    Zhu N; Wang Q; Wu Z; Wang Y; Zeng MS; Yuan Y
    J Virol; 2022 Mar; 96(5):e0194121. PubMed ID: 35019715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus-encoded latent membrane protein 1 promotes extracellular vesicle secretion through syndecan-2 and synaptotagmin-like-4 in nasopharyngeal carcinoma cells.
    Liao C; Zhou Q; Zhang Z; Wu X; Zhou Z; Li B; Peng J; Shen L; Li D; Luo X; Yang L
    Cancer Sci; 2020 Mar; 111(3):857-868. PubMed ID: 31930596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
    Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
    PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma.
    Wang Z; Xie J; Yan M; Wang J; Wang X; Zhang J; Zhang Y; Li P; Lei X; Huang Q; Lin S; Guo X; Liu Q
    Oncotarget; 2016 May; 7(18):26765-79. PubMed ID: 27049918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma.
    Xu S; Zhou Z; Peng X; Tao X; Zhou P; Zhang K; Peng J; Li D; Shen L; Yang L
    Cell Death Dis; 2021 Apr; 12(4):344. PubMed ID: 33795637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
    Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
    Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
    Chang PY; Wu ZZ; Sun NK; Chao CC
    J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies.
    da Costa VG; Marques-Silva AC; Moreli ML
    Syst Rev; 2015 Apr; 4():46. PubMed ID: 25927427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma.
    Chew MM; Gan SY; Khoo AS; Tan EL
    BMC Cancer; 2010 Oct; 10():574. PubMed ID: 20964870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.